NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors

TAIPEI, Aug. 3, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA). It will be initiated shortly at Linkou Chang Gung Memorial Hospital. The trial will...

from PR Newswire: https://ift.tt/37l486I